These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Parolini O; Alviano F; Bagnara GP; Bilic G; Bühring HJ; Evangelista M; Hennerbichler S; Liu B; Magatti M; Mao N; Miki T; Marongiu F; Nakajima H; Nikaido T; Portmann-Lanz CB; Sankar V; Soncini M; Stadler G; Surbek D; Takahashi TA; Redl H; Sakuragawa N; Wolbank S; Zeisberger S; Zisch A; Strom SC Stem Cells; 2008 Feb; 26(2):300-11. PubMed ID: 17975221 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives. Miki T; Grubbs B J Obstet Gynaecol Res; 2014 Feb; 40(2):360-8. PubMed ID: 24245961 [TBL] [Abstract][Full Text] [Related]
5. A Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases. Miki T Stem Cells Transl Med; 2016 Apr; 5(4):405-9. PubMed ID: 26941361 [TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of stem cell marker-positive cells in fetal and term human amnion. Izumi M; Pazin BJ; Minervini CF; Gerlach J; Ross MA; Stolz DB; Turner ME; Thompson RL; Miki T J Reprod Immunol; 2009 Jul; 81(1):39-43. PubMed ID: 19501410 [TBL] [Abstract][Full Text] [Related]
7. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. Miki T; Mitamura K; Ross MA; Stolz DB; Strom SC J Reprod Immunol; 2007 Oct; 75(2):91-6. PubMed ID: 17493686 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Tamagawa T; Ishiwata I; Saito S Hum Cell; 2004 Sep; 17(3):125-30. PubMed ID: 15859157 [TBL] [Abstract][Full Text] [Related]
9. Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules. Kadam SS; Sudhakar M; Nair PD; Bhonde RR Cytotherapy; 2010 Dec; 12(8):982-91. PubMed ID: 20807019 [TBL] [Abstract][Full Text] [Related]
10. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853 [TBL] [Abstract][Full Text] [Related]
11. Stem cell characteristics and the therapeutic potential of amniotic epithelial cells. Miki T Am J Reprod Immunol; 2018 Oct; 80(4):e13003. PubMed ID: 29956869 [TBL] [Abstract][Full Text] [Related]
12. Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease. Strom SC; Gramignoli R Hum Immunol; 2016 Sep; 77(9):734-9. PubMed ID: 27476049 [TBL] [Abstract][Full Text] [Related]
13. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. Toda A; Okabe M; Yoshida T; Nikaido T J Pharmacol Sci; 2007 Nov; 105(3):215-28. PubMed ID: 17986813 [TBL] [Abstract][Full Text] [Related]